LLY News and Press, Eli Lilly and Company From 03/09/24

2024-03-09 00:20:00 ET Summary The ALS drug (Relyvrio) had been put through a Phase II trial by its developer, Amylyx. Amylyx was already working on a Phase III trial, and they committed to withdrawing the drug if this trial showed no efficacy. Just like with the recent approv...

2024-03-08 22:16:08 ET Eli Lilly (NYSE: LLY) stock was on quite a roll this young year, but a new development shifted that momentum on Friday. The shares fell as much as 3.2% in price on Friday afternoon, following the news that a top regulator is delaying a decision on one of the c...

2024-03-08 14:28:57 ET More on Novo Nordisk Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified Novo Nordisk, A Very Healthy Pharma Stalwart Novo Nordisk: SOTP After Impressive FY23 And Weight Loss Going Mainstream, Maintain Buy Novo Nordi...

2024-03-08 12:10:25 ET More on Novo Nordisk Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified Novo Nordisk, A Very Healthy Pharma Stalwart Novo Nordisk: SOTP After Impressive FY23 And Weight Loss Going Mainstream, Maintain Buy Novo Nordi...

2024-03-08 11:25:31 ET More on Novo Nordisk Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified Novo Nordisk, A Very Healthy Pharma Stalwart Novo Nordisk: SOTP After Impressive FY23 And Weight Loss Going Mainstream, Maintain Buy Novo Nordi...

2024-03-08 10:55:16 ET More on S&P 500 Index: Employment February 2024: A Relief From Last Month But No Rate Cuts Any Time Soon February Jobs Report: A Mulligan After January Shocker A Goldilocks February Jobs Report: Stocks Rally, Yields Ease, Dollar Drops ...

2024-03-08 08:00:00 ET Summary Viking Therapeutics' stock initially surged after positive Phase 2 data for its obesity drug, but fell after Novo Nordisk shared data on a new, oral weight loss drug. Eli Lilly and Novo Nordisk have major potential in the obesity market with their dr...

2024-03-08 07:07:44 ET More on Eli Lilly Eli Lilly and Co (LLY) Cowen's 44th Annual Health Care Conference (Transcript) Eli Lilly: Will It Be The First Ever Trillion-Dollar Drug Company? Eli Lilly: Yes, It Is Too Late To Join The Party Novo Nordisk expects We...

U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab PR Newswire INDIANAPOLIS , March 8, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Admi...

2024-03-07 19:06:31 ET More on Novo Nordisk Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified Novo Nordisk, A Very Healthy Pharma Stalwart Novo Nordisk: SOTP After Impressive FY23 And Weight Loss Going Mainstream, Maintain Buy Biggest st...